Sort
82,697 grants matching “vaccine development”
Antibody Maturation Elicited by Integrase Defective Lentiviral Vectors
$719,278Michael Anthony Moody · Duke University · P01 · FY2019 · AI
Human antibodies for therapeutic intervention of staph enterotoxin B exposure
$719,213Luigi Grasso · Morphotek, Inc. · U01 · FY2008 · AI
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$719,193Anne Moscona · Columbia University Health Sciences · R01 · FY2019 · AI
Project 2
$719,107Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI
Targeting RIPK3 in Flu-Associated Lung Injury
$719,078Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · AI
Longitudinal Analysis of Immune Signatures (IMS) of M. tuberculosis-specific T cells
$719,048Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2025 · AI
Rocky Mountain Spotted Fever Vaccine Development
$718,983Roman R. Ganta · University Of Missouri-Columbia · R01 · FY2023 · AI
Sinusitis in Children and the Nasopharyngeal Microbiome
$718,967Ellen R. Wald · University Of Wisconsin-Madison · R01 · FY2014 · AI
Coronavirus Pathogenesis and Broadly Protective Vaccine Development
$718,928Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Administrative Core
$718,904David H Walker · University Of Texas Med Br Galveston · U54 · FY2009 · AI
Preclinical Evaluation of Envelope Immunogens Optimized to Elicit VRCOI-class An
$718,885Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2014 · AI
Development and maintenance of human glycan and phospholipid antibody repertoires
$718,871John Franklin Kearney · University Of Alabama At Birmingham · U19 · FY2023 · AI
AIDS Animal Models: Cellular Immunology and Immunogenetics
$718,836Bernard Lafont · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Determination of the Interactome between Haemophilus ducreyi and the Human Host.
$718,795Stanley M Spinola · Indiana University Indianapolis · R01 · FY2021 · AI
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
$718,789Connie Schmaljohn · Geneva Foundation · R01 · FY2013 · AI
BSL-3 Practices Core
$718,778Jeffrey Joseph Adamovicz · University Of Missouri-Columbia · UC7 · FY2024 · AI
MAb Passive Vaccination against Acinetobacter baumannii
$718,766Brad J Spellberg · University Of Southern California · R01 · FY2018 · AI
Effect of IL-21 treatment concurrent to ART and 3HP in Mtb/SIV co-infection
$718,758Riti Sharan · Texas Biomedical Research Institute · R56 · FY2024 · AI
HEPATITIS B AND C AMONG HOMELESS ADULTS
$718,703University Of California Los Angeles · R01 · FY2002 · DA
Defining the impact of host factors on the molecular architecture and bacterial physiology of Staphylococcus aureus abscesses
$718,675James E Cassat · Vanderbilt University Medical Center · R01 · FY2024 · AI
Pulmonary neuroimmune determinants of immunoglobulin production against pneumonia
$718,661Nicholas Jendzjowsky · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2025 · HL
Inhalation Therapy Platform for Coronavirus Infection Treatment
$718,653Patrick S. Stayton · University Of Washington · R01 · FY2024 · AI
Quantifying the Breadth and Duration of Immunity Induced by Meningococcal B Vaccines
$718,641Nicole Elaine Basta · University Of Minnesota · R01 · FY2019 · AI
Innate immune response of LTBI+HIV+ children
$718,640Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2020 · AI
Infant immunoprophylaxis against a primate lentivirus
$718,627Dana-Farber Cancer Institute · R37 · FY2003 · AI